Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Idram Becomes a Partner of “Little Mher”Unibank has launched instant transfers by phone number Unisport Crowned Armenian Futsal Premier League ChampionOn May 30, "Unisport" will compete for the title of the Armenian championWith IDBank’s Support, Ian Gillan and Tony Iommi Awards Established at Gyumri Music School No. 6An unforgettable day instead of toys: June 1st guide from Idram&IDBankUnibank Issues Perpetual Bonds with a 13.25% Annual Yield for Shareholders IDBank Presented It’s Vision for Social Responsibility at Impacture 2026Unibank will not increase fixed-adjustable interest rates on loans secured by real estate Ucom General Director Ralph Yirikian Participated in the Impacture 2026 Conference“We are switching you to 5G, type a command”: IDBank warns about a fraud disguised as a “network update”Ucom and staff.am Bring Together Armenia’s Business Leaders at Executive Offsite Vol.1 Ameriabank and ADB Signed a $100 Million Agreement to Expand Micro, Small, and Medium-Sized Enterprise and Green Finance in ArmeniaLove Is… card from Unibank can win a trip to Paris Learn by Playing. A Series of Financial Literacy Games with Idram, IDBank and “Novosti-Armenia”Ucom and the Microsoft Innovation Center Collaborate on Cybersecurity EducationUnisport – Armenian Futsal Cup holderSummer starts with iced coffee, what if it brings bonuses too? Idram&IDBank AraratBank reduces loan interest rates for around 400 reliable SME customersTeam Holding Announces the Launch of the Third and Final Placement Phase of USD Bonds. Underwriter - Freedom Broker Armenia
All Timeline »
Life

Multiple sclerosis drug shows promising efficacy

The multiple sclerosis drug is showing promising efficacy in fighting relapses and reducing fatigue.

Back in March 2001, the US Food and Drug Administration approved a drug called ponosimod for use in adult patients with various types of multiple sclerosis. Only now there are research data that show that some drug reduces the number of relapses of the disease and can reduce fatigue - one of the characteristic symptoms of multiple sclerosis.

The respected scientific journal JAMA Neurology has found that ponesimod is more effective in fighting fatigue in multiple sclerosis than another commonly used drug called teriflunomide. It is superior to teriflunomide in reducing relapse rates and reducing the risk of new or existing lesions of myelin found on magnetic resonance imaging.

As reported by everydayhealth.com, ponesimod is used for various types of multiple sclerosis, including the most common relapsing remitting disease and active secondary progressive, which is the most severe. It is not accompanied by remissions and steadily leads to the disability of patients. It is people with this form of multiple sclerosis who show the appearance of new lesions of the myelin layer on MRI scans. Ponesimod must be taken once a day, treatment begins with a period of 14 days, then the doses are increased.